FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Markus Wild
List of publications:
BibTeX-Download
Institute of Clinical and Molecular Virology
Publications
(10)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target (2024)
Marschall M, Schütz M, Wild M, Socher E, Wangen C, Dhotre K, Rawlinson WD, Sticht H
Journal article
Autofluorescent Artemisinin-Benzimidazole Hybrids via Organo-Click Reaction: Study of Antiviral Properties and Mode of Action in Living Cells (2023)
Herrmann L, Hahn F, Grau B, Wild M, Niesar A, Wangen C, Kataev E, et al.
Journal article
Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers. (2023)
Wild M, Karner D, Eickhoff J, Wagner S, Kicuntod J, Chang W, Barry P, et al.
Journal article
Cyclin‐Dependent Kinases (CDKs) and the Human Cytomegalovirus‐Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations (2022)
Wild M, Hahn F, Brückner N, Schütz M, Wangen C, Wagner S, Sommerer M, et al.
Journal article
Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity (2021)
Hahn F, Hamilton ST, Wangen C, Wild M, Kicuntod J, Brückner N, Follett JE, et al.
Journal article
Combinatorial drug treatments reveal promising anticytomegaloviral profiles for clinically relevant pharmaceutical kinase inhibitors (PKIs) (2021)
Wild M, Kicuntod J, Seyler L, Wangen C, Bertzbach LD, Conradie AM, Kaufer BB, et al.
Journal article
The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism (2020)
Wild M, Hahn F, Grau B, Herrmann L, Niesar A, Schütz M, Lorion MM, et al.
Journal article
Target verification of artesunate-related antiviral drugs: Assessing the role of mitochondrial and regulatory proteins by click chemistry and fluorescence labeling (2020)
Hahn F, Niesar A, Wangen C, Wild M, Grau B, Herrmann L, Capci A, et al.
Journal article
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice (2020)
Wild M, Bertzbach LD, Tannig P, Wangen C, Müller R, Herrmann L, Fröhlich T, et al.
Journal article
Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus (2019)
Bertzbach LD, Conradie AM, Hahn F, Wild M, Marschall M, Kaufer BB
Journal article